Public signalCompany raiseAuto-indexed · Unverified
Kairos Pharma, LTD. raised $3.5M
Kairos Pharma, LTD.· LOS ANGELES, US· Pharmaceuticals· Filed Jan 28, 2025
Kairos Pharma, LTD. reported raising capital. Based in LOS ANGELES, CALIFORNIA, US. First sale reported 2025-01-16. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$3.5M
Confidence90%
Raised
$3.5M
Investors
1
Jurisdiction
DELAWARE
On the record
- Location
- LOS ANGELES, US
- Sector
- Pharmaceuticals
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $3.5M
- Target amount
- $8.8M
- Filing date
- Jan 28, 2025
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Industry group
- Pharmaceuticals
- Number of investors
- 1
- Includes non-accredited investors
- Yes
- Revenue range
- Decline to Disclose
- Total offering amount
- $8.8M
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Sources & provenance
“Operating company sold 3,497,500 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Jan 28, 2025. Details beyond the filing have not been verified.
Tags
USCompanyPharmaceuticals$1M – $10MCompany Raise
Are you associated with Kairos Pharma, LTD.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record